Expand Treatment Access/Opioid Use Disorder.

HB 824 aims to expand access to treatment for opioid use disorder and overdose for individuals covered by health benefit plans. It requires health insurers to cover specific healthcare services provided by pharmacists, such as testing and medication administration, if those services are within a pharmacist's scope of practice. The bill also mandates coverage for all FDA-approved prescription drugs for opioid disorder and overdose, prohibiting prior authorization for these medications. Additionally, it updates state laws to ensure mental health benefits in health plans are no less favorable than physical health benefits, aligning with federal requirements.